Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.
暂无分享,去创建一个
R. Gelber | S. Sallan | N. Tarbell | J. Cassady | R. Tantravahi | H. Cohen | L. Clavell | S. Blattner | P. Leavitt | S. Hitchcock-bryan
[1] M. Amylon,et al. Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study. , 1986, The New England journal of medicine.
[2] A. Bleyer,et al. Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] F. Lampert,et al. Acute Lymphoblastic Leukaemia , 1986 .
[4] L. Frankel,et al. Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: a Pediatric Oncology Group Study. , 1986, Blood.
[5] H. Sather,et al. Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children's Cancer Study Group. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] S. Sallan,et al. Comparative analysis of treatment programs for childhood acute lymphoblastic leukemia. , 1985, Seminars in oncology.
[7] S. Sallan,et al. Cardiac effects of anthracyclines used in the treatment of childhood acute lymphoblastic leukemia: a 10-year experience. , 1984, Seminars in oncology.
[8] R. Gelber,et al. Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. , 1983, Cancer research.
[9] J. Belli,et al. Efficacy and morbidity of central nervous system prophylaxis in childhood acute lymphoblastic leukemia: eight years' experience with cranial irradiation and intrathecal methotrexate , 1983 .
[10] H. Sather,et al. Prolonged second remissions in childhood acute lymphocytic leukemia: a report from the Childrens Cancer Study Group. , 1983, Medical and pediatric oncology.
[11] S. Sallan. T-cell acute lymphoblastic leukemia in children. , 1981, Haematology and blood transfusion.
[12] J. Herson,et al. Favorable response to maintenance therapy of second or subsequent remissions in childhood acute lymphocytic leukemia , 1980, Cancer.
[13] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[14] Ellis L. Reinherz,et al. The differentiation and function of human T lymphocytes , 1980, Cell.
[15] R. Gelber,et al. Cell surface antigens: prognostic implications in childhood acute lymphoblastic leukemia. , 1980, Blood.
[16] H. Lazarus,et al. A monoclonal antibody to human acute lymphoblastic leukaemia antigen , 1980, Nature.
[17] S. George,et al. A reappraisal of the results of stopping therapy in childhood leukemia. , 1979, The New England journal of medicine.
[18] R. Aur,et al. Recurrent childhood lymphocytic leukemia. Clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission , 1978, Cancer.
[19] S. Sallan,et al. Intermittent combination chemotherapy with adriamycin for childhood acute lymphoblastic leukemia: clinical results. , 1978, Blood.
[20] D. Cox,et al. The analysis of binary data , 1971 .
[21] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .